Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management

Area of Science:

• Pharmacology
• Pain Management
• Immunology

Background:

• Naltrexone is an opioid receptor antagonist approved for opioid and alcohol dependence.
• Standard naltrexone dosage is 50-100 mg daily.
• Low-dose naltrexone (LDN) is being investigated for chronic pain and other conditions.

Purpose of the Study:

• To present a case study of a patient with idiopathic hypereosinophilic syndrome (IHES) experiencing pain.
• To evaluate the efficacy of low-dose naltrexone in managing pain associated with IHES.
• To highlight the potential of LDN as an alternative treatment for refractory chronic pain.

Main Methods:

• A case study approach was used.
• The patient received low-dose naltrexone therapy.
• Pain levels and disease status were monitored.

Main Results:

• The patient experienced pain associated with idiopathic hypereosinophilic syndrome.
• Low-dose naltrexone treatment was administered.
• The study details the patient's response to LDN for pain management.

Conclusions:

• Low-dose naltrexone may be a viable treatment option for chronic pain in conditions like IHES.
• Further research is warranted to explore the efficacy and safety of LDN for various chronic pain conditions.
• The findings contribute to the growing evidence supporting the use of LDN in pain management.